This technology has its unique advantages of ultrahigh sensitivity, high accuracy, velocity, and being user-friendly. Speaking of applications, in addition to COVID19 RNA rapid test that we have received an EUA from Taiwan’s FDA, this technology could cover a variety of applications, including but not limited to: the detection of multiplex respiratory disease, clinical application of diabetes and kidney diseases, the detection of animal cancers, the test of environmental chemicals, and so on. The makers of biomarkers could also leverage this technology to validate the specificity of antibodies.